Future Journal of Pharmaceutical Sciences

Table 4 Recovery study

From: Development and validation of stability-indicating RP-HPLC method for the simultaneous estimation of xylometazoline hydrochloride and ipratropium bromide from nasal spray dosage form

	Xylometazoline		Ipratropium bromide
Recovery level in %	% Recovery	% Average recovery	% Recovery	% Average recovery
50%	99.7	99.4	98.5	98.3
	99.2		98.3
	99.4		98.2
100%	101.2	101.1	101.4	101.3
	101.3		101.4
	100.9		101.2
150%	101.6	101.6	101.6	101.5
	101.5		101.5
	101.6		101.5

Back to article page